Goldman Sachs’s Treace Medical Concepts TMCI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$519K	Buy	387,685 +198,833	+105%	+$396K	﹤0.01%	5574
2025 Q4	$463K	Sell	188,852 -25,812	-12%	-$112K	﹤0.01%	5637
2025 Q3	$1.44M	Sell	214,664 -20,491	-9%	-$134K	﹤0.01%	4754
2025 Q2	$1.38M	Sell	235,155 -24,422	-9%	-$159K	﹤0.01%	4464
2025 Q1	$2.18M	Sell	259,577 -205,227	-44%	-$1.84M	﹤0.01%	4089
2024 Q4	$3.46M	Sell	464,804 -200,348	-30%	-$1.34M	﹤0.01%	3812
2024 Q3	$3.86M	Buy	665,152 +416,060	+167%	+$2.67M	﹤0.01%	3582
2024 Q2	$1.66M	Buy	249,092 +151,134	+154%	+$1.22M	﹤0.01%	4058
2024 Q1	$1.28M	Sell	97,958 -255,564	-72%	-$3.41M	﹤0.01%	4181
2023 Q4	$4.51M	Buy	353,522 +231,471	+190%	+$2.34M	﹤0.01%	3255
2023 Q3	$1.6M	Buy	122,051 +5,313	+5%	+$97.2K	﹤0.01%	3936
2023 Q2	$2.99M	Sell	116,738 -6,963	-6%	-$180K	﹤0.01%	3555
2023 Q1	$3.12M	Buy	123,701 +97,115	+365%	+$2.28M	﹤0.01%	3495
2022 Q4	$611K	Sell	26,586 -5,642	-18%	-$130K	﹤0.01%	4750
2022 Q3	$711K	Buy	32,228 +18,444	+134%	+$357K	﹤0.01%	4748
2022 Q2	$198K	Buy	13,784 +45	+0.3%	+$758	﹤0.01%	5645
2022 Q1	$260K	Buy	+13,739	New	+$267K	﹤0.01%	5740
2021 Q3	–	Sell	-11,651	Closed	-$364K	–	6513
2021 Q2	$364K	Buy	+11,651	New	+$371K	﹤0.01%	5403